iBio, Inc.: Frazier Life Sciences Public Fund, L.P. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Frazier Life Sciences Public Fund, L.P. amended its Schedule 13G stake filing for iBio, Inc., per SEC accession 0001231919-26-001582. The amendment updates the fund's reported ownership position in the biotech, though the filing summary disclosed no revised share count or percentage. Investors will watch for the full filing details to gauge whether Frazier's position increased, decreased or was unchanged.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
iBio, Inc., Frazier Life Sciences Public Fund, L.P.